secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inotiv, Inc. (NOTV)
CIK:        0000720154
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0001104659-22-088629
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inotiv Q3 FY2022 revenue rises to $172.7M; raises FY2022 revenue guidance to at least $550M
--------------------------------------------------------------------------------

- Q3 FY2022 revenue $172.7M vs $22.9M a year ago; DSA revenue $49.2M (+114.8% YoY), RMS $123.4M from nil.
- Net loss $(3.6)M vs net income $2.6M in Q3 FY2021; adjusted EBITDA $37.0M (21.4% rev) vs $2.2M (9.6%).
- Raises FY2022 revenue guidance to at least $550M (from $510M); adjusted EBITDA margin at least 17.0% (from 15.0%).
- DSA backlog $143.2M at June 30, 2022, up from $62.0M a year ago; book-to-bill 1.19x.
- YTD cash used in ops $5.4M; debt $338.8M; subsequent acquisition of Protypia for large molecule bioanalysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/720154/000110465922088629/0001104659-22-088629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/720154/000110465922088629/tm2223117d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-088629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer